Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
07 March 2019 | Story Rulanzen Martin | Photo Rulanzen Martin
CGAS staff with Jessica Lynn
From left: Ankia Bradfield, Sihle Salman, Jessica Lynn, Dr Nadine Lake, programme director, Gender Studies, and Dr Stephanie Cawood, director of CGAS after the talk.

For Jessica Lynn, a transgender activist, referencing the Butterfly to tell her journey, is the perfect metaphor to raise awareness of transgender issues. The Centre for Gender and Africa studies (CGAS) at the University of the Free State (UFS) hosted Lynn at a seminar titled, The Butterfly Project.

The CGAS invited Lynn in an effort to educate and inform students of her own experience as a parent living as a transgender woman. She is a global ambassador at the Kinsey Institute.

Coping mechanisms to escape reality

Born Jeffery Alan Butterworth in 1965, Lynn has become a world-renowned, dynamic and hard-hitting transgender activist. Lynn started her seminar off with: “Who here knows someone that is part of the transgender community?” It was evident that not many people know someone who is transgender. “In the United States only 16% of the population knows someone who is transgender,” she said.

“Everybody has their own story, just like I am only one of the 1.4 million transgender stories in the United States (US).” As a child of English immigrants to the US she was raised as a boy. “At a very young age I wanted to be girl,” she says, “but in 1969 it was not something that was spoken about..”

She started doing photography, painting and sports to stop the feelings she had to become a girl. She became obsessed with painting. “When I am painting that eagle I became that eagle in order to escape my reality.” She came out to her children as transgender during December 2009. She fully transitioned in 2010.

Lynn is the mother of three boys and was married to their biological mother. A botched Texas court restricted her access to her youngest child and to this day she has not been able to see her son.

Transgender discussions on rise in South Africa

“Transgender discussions have been less salient than conversations around homosexuality in South Africa,” said Dr Nadine Lake, programme director for Gender Studies at the UFS.  “But it is clear that raising awareness around transgender issues is starting to take more ground.”

Transgender identity and trans-body rights emerged during the #RhodesMustFall movement in 2015. “It was university students that were primarily driving the transformation agenda,” said Dr Lake.

The seminar on 20 February 2019 was an emotional, explosive and honest narrative of Jessica Lynn cocooning from Jeffrey Alan Butterworth to the phenomenal women she is today.

 

News Archive

Nano research at the UFS opens door to smart drugs
2011-06-27

 

Prof. Lodewyk Kock, outstanding professor in our Department of Microbial, Biochemical and Food Biotechnology

Novel antifungal, anticancer and anti-malaria drugs that have been identified in the research of Prof. Lodewyk Kock, outstanding professor in the Department of Microbial, Biochemical and Food Biotechnology at our university, will be disclosed later this year at major international conferences in Asia, Europe and the USA. Prof. Kock will be the keynote speaker at these conferences. 

His presentations will be based on the department’s discovery of yeast assays linked to a new nanotechnology for medicine. The assays were recently discovered by his group and can be applied in the development of novel antifungal, anticancer and anti-malaria drugs.
 
Prof. Kock’s focused research at the university, which now also includes his novel nanotechnology for Biology, began in 1982 in collaboration with Prof. Pieter van Wyk (Centre for Microscopy). He recently collaborated with Prof. Hendrik Swart (Department of Physics).
 
Prof. Kock says the development of novel anti-malaria drugs in particular is getting attention across the world due to the high rates of morbidity and mortality caused by the disease worldwide. Approximately 225 million people are infected annually and about a million (many in Africa) die each year. “Many potential smart drugs have been identified with this research and should now be tested further,” says Kock.
  
These new drugs will be disclosed during Prof. Kock’s keynote addresses at the International Conference and Exhibition on Pharmaceutical Regulatory Affairs in Baltimore, USA, from 6 to 7 September 2011, the Medichem 2011 in Beijing, China from 9 to 11 August 2011 and the XVI Congress of European Mycologists in Greece, from 19 to 23 September 2011.

 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept